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Highlights 
 Combined molecular and epidemiological data can describe the spread of  
gonorrhoea 
 Sexual networks can be inferred from molecular clusters of infection 
 Gender and sexual orientation are commonly used to characterise these networks 
 Application of these data within gonorrhoea control interventions is limited 
 Future studies should focus on evaluating molecular typing data in practice 
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Summary 
Objectives 
Neisseria gonorrhoeae (NG) is a significant global public health concern due to rising 
diagnoses rates and antimicrobial resistance. Molecular combined with epidemiological data 
have been used to understand the distribution and spread of NG, as well as relationships 
between cases in sexual networks, but the public health value gained from these studies is 
unclear. We conducted a systematic review to examine how molecular epidemiological 
studies have informed understanding of sexual networks and NG transmission, and 
subsequent public health interventions. 
 
Methods 
Five research databases were systematically searched up to 31st March 2017 for studies 
that used sequence-based DNA typing methods, including whole genome sequencing, and 
linked molecular data to patient-level epidemiological data. Data were extracted and 
summarised to identify common themes. 
 
Results 
Of the 49 studies included, 82% used NG Multi-antigen Sequence Typing. Gender and 
sexual orientation were commonly used to characterise sexual networks that were inferred 
using molecular clusters; clusters predominantly of one patient group often contained a small 
number of isolates from other patient groups. Suggested public health applications included 
using these data to target interventions at specific populations, confirm outbreaks, and 
inform partner management, but these were mainly untested. 
Conclusions 
Combining molecular and epidemiological data has provided insight into sexual mixing 
patterns, and dissemination of NG, but few studies have applied these findings to design or 
evaluate public health interventions. Future studies should focus on the application of 
molecular epidemiology in public health practice to provide evidence for how to prevent and 
control NG.  
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Introduction 
Neisseria gonorrhoeae is a sexually transmitted pathogen of significant public health 
concern due to rising diagnosis rates, particularly in men who have sex with men (MSM), 
and the emergence of resistance to all classes of antimicrobials used for treatment.1,2 It is 
important to better understand how and why N. gonorrhoeae and resistant infections spread 
within sexual networks in order to design targeted and rational interventions to control 
transmission. 
 
Traditional epidemiological methods using surveillance data and patient questionnaires of 
reported behaviour to understand and describe sexual networks have been used to improve 
our understanding of the distribution and transmission of N. gonorrhoeae, including the 
concentration of N. gonorrhoeae in specific groups at risk.3,4 However, these methods are 
limited in their ability to determine whether infected individuals with the same epidemiological 
characteristics are part of the same transmission network. Establishing direct 
epidemiological links is challenging because gonorrhoea is frequently asymptomatic, 
especially in females, which may lead to missing (undiagnosed) cases in most datasets. 
 
Molecular technologies can be used to group isolates according to similarities in their genetic 
data and infer relatedness between isolates.5 By combining these molecular data with 
epidemiological data, hypotheses about the transmission of N. gonorrhoeae within and 
across different sexual networks can be tested. The use of molecular epidemiology in the 
analysis of N. gonorrhoeae populations is a rapidly evolving field but there has been no 
systematic assessment of its public health value. 
 
 
In this systematic review, we aimed to use published literature to investigate how linked N. 
gonorrhoeae epidemiological and molecular typing data can enhance our understanding of 
sexual networks and pathogen transmission and how this information has been used within 
public health interventions to control gonorrhoea infections. 
Methods 
Search strategy and selection criteria 
In this systematic review (reported according to the international prospective register of 
systematic reviews: PROSPERO 2016 CRD 42016037238),6 studies were included if 
sequence based DNA typing methods were used (Multi-locus Sequence Typing (MLST), N. 
gonorrhoeae Multi-Antigen Sequence Typing (NG-MAST) and Whole Genome Sequencing 
(WGS)) (see Supplementary material for Glossary of Terms) and the typing data were linked 
to patient-level epidemiological data, including patient demographic data (e.g. gender, age, 
and ethnicity), sexual behaviour data (e.g. sexual orientation, sex work, condom use, 
number of partners, sex abroad) and/or clinical data (e.g. symptoms, site of infection, 
concurrent STIs, HIV status). We focused on the sequence-based DNA typing techniques 
described above, as these are currently the most commonly used and recommended7 
techniques for molecular epidemiological studies. Studies were excluded if the articles were 
not in English, if the typing data were only linked to the geographical location and/or date of 
the isolates and not to patient epidemiological data, if typing data were only used to 
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investigate the pathobiology of N. gonorrhoeae, or to develop methods for typing of N. 
gonorrhoeae. 
 
We searched Web of Science, Scopus, MEDLINE, EMBASE, and the Cochrane library from 
inception to 31st March 2017. Search terms included the typing methods of interest (NG-
MAST, MLST, and WGS) and terms related to Neisseria gonorrhoeae. The full search 
strategies are detailed in the Supplementary Material, including details of conference 
abstract books that were searched for relevant studies.  
 
The title, abstract and then full text of studies were assessed against the eligibility criteria. 
Where no full text was found, study authors were contacted by email to request a copy of the 
paper. Authors of conference abstracts were also contacted for the poster or presentation 
slide set. 
Data extraction and synthesis 
Data were extracted using a standardised form and summarised in a descriptive table. 
Common themes were identified and are presented using a narrative approach. Risk of bias 
was assessed considering the potential for (1) selection bias affecting the interpretation and 
generalisability of results based on the isolates with typing data available and the wider 
population that the study aimed to represent, (2) missing data bias, and whether data were 
likely to be missing at random or not, and (3) reporting bias, particularly for reported 
behavioural variables. 
 
Dual independent review 
Each article was reviewed, data extracted and risk of bias assessed independently by two 
reviewers (KT and HB, or KT and SC); disagreements were resolved at a meeting between 
the reviewers. 
 
Results 
Article screening 
Our search strategy identified 4,759 studies, of which 2,101 were unique (Figure 1). Most 
studies were excluded following title and abstract review (94%; 1,982/2,101). Of the 
remaining 119 studies, 50 met the study eligibility criteria (42%; 50/119). One study was not 
reviewed as the full-text could not be accessed.8 Studies were most commonly excluded at 
this stage because no patient data were reported (74%; 51/69). Nine conference abstracts 
were identified, four of which had been subsequently published. Authors for the remaining 
five were contacted for the presented poster or slide set but none replied (Supplementary 
material). Hence, 49 studies were included in this systematic review. 
 
Description of included studies  
Over one third of studies used isolates collected in the UK (37%; 18/49),9-26  from 
consecutive patients during the study time period (35%; 17/49),11,14-17,21,22,24,27-35 or limited 
inclusion of isolates to those known to be resistant to a specific antimicrobial (35%; 
17/49).9,10,13,18-20,23,36-45  The number of isolates sampled ranged from six to 3,326, with 
studies covering a time period of less than six months to nine years (Supplementary 
Material).  
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Most studies used NG-MAST (82%; 40/49),9-22,26-33,35-44,46-53  two used MLST (4%; 2/49),34,54  
and seven used WGS (14%; 7/49),23-25,45,55-57 (Figure 2). The WGS studies also determined 
the NG-MAST and/or MLST sequence type in silico and compared typing methods. Although 
the clustering identified through NG-MAST and MLST methods broadly correlated with the 
clustering determined by WGS-based phylogenetic analyses, the WGS analyses showed 
that the other methods sometimes misclassified clustering. For example, Didelot et al.25 
showed that isolates with an identical NG-MAST type that occurred within the same time 
period and location, and which would otherwise have been considered to be part of the 
same sexual network, were actually genetically distinct when WGS was used.  
Risk of bias 
Most studies applied specific selection criteria to the isolates chosen for typing, which mainly 
related to the setting and location isolates were selected from, the time period for data 
collection, or the selection of isolates with a specific antimicrobial susceptibility profile. This 
may limit the generalisability of the results. Most studies typed ≥70% of isolates eligible 
under the predetermined selection criteria of the study. The main reasons not all isolates 
were typed were that the isolate could not be retrieved or the typing method failed. In 
general missing epidemiological data were minimal. However, most studies did not define 
how patient-level variables were collected, and it was therefore often difficult to assess 
reporting bias. It is likely that variables related to sexual behaviour, such as sexual 
orientation, were self-reported, which increases the risk of reporting bias. Further details for 
each study are presented in the supplementary material. 
Patient-level epidemiological data 
The most commonly reported and linked patient-level epidemiological data were gender 
(reported 100%; 49/499-57, linked 90%; 44/499,11-44,46-49,53-57) and sexual orientation (reported 
82%; 40/499-11,13-23,25-30,32,33,36-42,45-53,55,57, linked 71%; 35/499,11,13-23,25-30,32,33,36-42,46-49,53,55,57). 
Other patient-level epidemiological data (not always linked to molecular data) included age, 
sexual partner history (such as the number of sexual partners), location of patient residence 
or clinic, site of infection, travel associated sex, STI history, patient HIV status, patient 
ethnicity, infection symptoms and sexual behaviour (Figure 3). 
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Figure 1: PRISMA flowchart indicating the systematic selection of journal articles for 
inclusion in this review 
PRISMA flowchart for the conference abstract book is presented in the Supplementary 
Material. 
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Figure 2: Number of studies by typing method over time (N=49) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
NGMAST = Neisseria gonorrhoeae multi-antigen sequence typing 
MLST = multi-locus sequence typing 
WGS = whole genome sequencing 
 
Figure 3: Reporting and linkage of patient epidemiological data to typing data (N=49) 
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Summary of study findings 
Identifying clusters of infection, sexual networks and transmission links 
The majority of studies that used NG-MAST or MLST defined a cluster by the presence of 
two or more isolates with identical sequence types.9,10,16,29,31,42 Closely related sequence 
types (defined as varying genetically by ≤1%) were sometimes grouped into larger 
categories called genogroups based on sequence similarity. Most studies identified a large 
number of different sequence types: many of which had not been identified before (‘novel’ 
sequence types) and/or were present only once in the isolate set (‘unique’ sequence 
types).29-31,53 For example, Chisholm et al (2013)29 found 406 NG-MAST sequence 
typesamongst 1,066 isolates. Over half of these were novel (216/406) and/or unique 
(281/406). WGS studies used maximum likelihood or Bayesian phylogenetic statistical 
modelling techniques with information on the number of single nucleotide polymorphisms 
(SNPs) to identify similarities and allocate isolates into clusters. 
The molecular data were also used to provide evidence about the likelihood that 
transmission of N. gonorrhoeae had occurred between two patients.9,11,12,14,16,17,23-25,38,53 The 
degree of concordance between sexual contact pairs (confirmed through partner notification 
data) and genetic data, such as NG-MAST sequence type, was >85% in these studies.  
Describing sexual networks using typing and patient-level epidemiological data 
Patient-level epidemiological data were used to characterise and compare clusters of 
infection (Figure 3). For example, Horn et al.31 found that isolates classified as genogroup 25 
were predominantly from women, whereas those classified as genogroup 1407 were 
predominantly from men. In general, only the most common sequence types, which formed 
the largest clusters, were described in this way.10,11,15-19,21,27,31,32,40,47,48,50,53 Where sequence 
typeswere statistically associated with one group of patients, such as MSM, authors inferred 
that this provided evidence of a discrete sexual network. Further examples are described 
below: 
(i) Sexual orientation: 
Overall, 38 studies investigated the relationship between sexual orientation and N. 
gonorrhoeae sequence type. Most (87%; 33/38) identified a difference in the 
sequence types circulating between MSM and heterosexual patients. For example, 
Cole et al.16 found a statistically significant association between NG-MAST sequence 
types and sexual orientation: sequence types 147, 4, 1634 and 64 were more likely 
to be from MSM than heterosexual patients. However, often, clusters with a 
predominating patient characteristic also contained a small number of isolates from 
other patient groups. For example, Wong et al.32 found that NG-MAST sequence type 
547 was associated with MSM but four of the 16 isolates were from heterosexual 
men. There was evidence of the same sequence type being associated with different 
sexual orientation characteristics in other studies. For example, using isolates 
collected in 2003, Abu-Rajab et al.11 found that NG-MAST sequence type 210 was 
associated with heterosexuals in Glasgow, Scotland. A year later, in 2004, 
Choudhury et al.15 found the same NG-MAST sequence type was associated with 
MSM in London, England. 
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(ii) Sub-groups within MSM and heterosexual networks: 
Half of the studies that included patient sexual orientation (17/38) investigated the 
existence of discrete transmission clusters within larger sexual networks by 
separately analysing the association between sequence types and patient variables 
within these sub-groups of the population. This enhanced analysis helped describe 
clusters of infection in more detail. For example, Choudhury et al.15 found that 
isolates from heterosexual patients had NG-MAST sequence types that varied by 
ethnicity and age, indicating discrete sexual networks, but they did not identify similar 
patterns associated with specific characteristics in MSM. In contrast, Bernstein et 
al.27 found that some NG-MAST sequence types were associated with specific 
characteristics in MSM. For example, isolates classified as NG-MAST sequence type 
2992 were more likely to be from MSM who reported oral sex only, and other NG-
MAST sequence types varied by reported sexual risk behaviour (three or more 
sexual partners compared to fewer sexual partners). 
(iii) HIV status: 
There were 10 studies that compared patient HIV status to the typing data to 
investigate whether the molecular data provided evidence of discrete sexual 
networks in people with and without HIV.15-17,27,32,42,46,47,50,53 Not all studies found the 
same result, which is likely due to the different populations and sexual behaviours of 
these populations investigated in each study. For example Didelot et al.25 found that 
N. gonorrhoeae was more likely to be transmitted between two HIV-positive patients 
than between a HIV-positive and HIV-negative patient, suggestive of serosorting 
sexual behaviour (the term for engaging in condomless anal intercourse with partners 
of the same known or presumed HIV status).58 However, Bernstein et al.27 and 
Cheng et al.47 did not find an association between molecular clusters and HIV status. 
 (iv) Travel-associated sexual partnerships: 
In 13 studies9-11,13,15,16,19,20,24,25,28,30,43, the molecular typing data was used to describe 
and investigate the role of travel-associated sexual partnerships on N. gonorrhoeae 
transmission and acquisition. Some studies found that unique sequence types were 
more likely to have been acquired outside of the local area, whereas clustered 
isolates were more likely to have been acquired within the local area10,15,19,20. 
Fernando et al.17 found that patients attending a specialist STI clinic in Edinburgh, 
Scotland, infected with unique N. gonorrhoeae NG-MAST sequence types were more 
likely to have reported recent sexual contacts from outside the local area. Similarly, 
Martin et al. (2005)10 found that the common strains types identified in London, 
England, were more likely to be from patients who did not report sex abroad. 
 
Describing antimicrobial resistance (AMR) within sequence types 
 
To describe and identify sequence types of N. gonorrhoeae associated with AMR, 
phenotypic antimicrobial susceptibility data were combined with molecular typing data in 
83% of studies (41/49). These studies found that susceptible N. gonorrhoeae were 
genetically more diverse than resistant N. gonorrhoeae, as evidenced by the higher number 
of different NG-MAST sequence types in the susceptible clones.36,49,54 Non-susceptible N. 
gonorrhoeae tended to be more clonal, for example, N. gonorrhoeae with decreased 
susceptibility to cefixime was usually detected in isolates identified as the NG-MAST 
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sequence type 1407.13,18,30,31,36,37,48,53 Similar clonality of the gonococcal population was 
found for other antimicrobial resistant phenotypes, such as ciprofloxacin, penicillin and 
tetracycline. Azithromycin resistance was found to occur sporadically in the gonococcal 
population rather than be associated with a particular clone,42,55 with the exception of high-
level azithromycin resistant isolates (minimum inhibitory concentration >256mg/L) that were 
found in clusters of closely related gonococci.14,23,35,44 
When the phenotypic data, molecular data and patient-level epidemiological data were all 
combined, this provided more insight into the distribution and spread of resistant N. 
gonorrhoeae infection in sexual networks or across populations.10,14,21,27,29,47,50,56,57 For 
example, using WGS, Grad et al. (2014)57 reported that N. gonorrhoeae with decreased 
susceptibility to cefixime first appeared on the west coast of the United States and then 
spread eastwards primarily within MSM networks, but with a small number of diagnoses in 
heterosexual patients. Authors often compared their findings to other studies to assess 
whether there were sexual networks operating between cities or countries and how this 
contributed to the spread of resistant infection. For example, Chisholm et al. (2009)14 
speculated that high-level azithromycin-resistant N. gonorrhoeae (MIC ≥256 mg/L) identified 
in Liverpool, England, was imported from Scotland because the NG-MAST sequence types 
(ST649), AMR phenotype and sexual orientation of the infected patients matched those of 
cases previously reported by Palmer et al. (2008).21  
Public health application of findings from included studies 
Many studies stated that combining molecular typing data and patient-level epidemiological 
data could be used to support decisions about N. gonorrhoeae prevention and control 
activities (Table 1). Over half of the studies (54%; 26/49)9-11,15-22,24,25,27,32-34,39-41,44,50,51,56,57 
suggested that these data could be used to identify which patient groups to target for public 
health interventions in order to maximise the effectiveness of resources. Other public health 
uses of the typing data included confirming outbreaks of new strains, including AMR 
infection,9,20,23,26,52 or using the data to evaluate existing public health interventions,9,10,22,30,49 
such as confirming the success of partner notification in a population. For example, Monfort 
et al. concluded that the high number of single STs in their sample was probably due to the 
lack of effective contact tracing. Similarly, many studies (22%; 11/49)11,12,15,16,19,22,24-26,51,57 
suggested that the molecular data could support contact tracing by providing complementary 
or confirmatory information. 
Over one third of studies (39%; 19/49)9,11,16,17,19,23,26-29,32,34,36,37,42,45-47,55 suggested the 
information could be used to tailor the clinical management that individual patients receive. 
For example, if a patient is infected with a strain associated with AMR, an ongoing outbreak 
or coinfection with another STI, they might be provided with enhanced clinical care, either 
informing antimicrobial choice or prioritising the patient for test-of-cure and partner 
notification. Several studies23,33 highlighted the importance of undertaking localised and 
prospective molecular epidemiological studies in order to identify changing trends in 
sequence types that may be indicative of new gonorrhoea outbreaks. 
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Table 1: Potential uses of molecular epidemiology to support or evaluate public health 
interventions suggested by reviewed studies 
Public health intervention Potential use of molecular epidemiology 
Outbreak investigation 
 
- the similarity between NG DNA has been used to confirm 
whether cases are related and potentially part of an 
outbreak
23,26,52
 
- modelling using WGS has been used to estimate the number 
of undetected cases in an outbreak
25
  
 
 
Sexual partner tracing 
 
 
- as with outbreak investigation, genetic similarities or 
differences between NG isolates might be used to inform 
sexual partner tracing and complement partner notification 
data
11,12,15,16,19,22,24,25,51,57
  
- identifying likely transmission between isolates using WGS 
data has been used to determine the density of sexual 
networks and speed of transmission
24,25
 
 
Antibiotic selection for patient 
management 
 
- associations found between specific sequence types and 
antimicrobial resistance may be used to guide patient treatment 
where phenotypic resistance data are unavailable or 
delayed
11,16,34,42,45,55
 
 
Targeted health 
promotion/behavioural 
interventions 
 
- associations found between specific sequence types and sub-
groups of the population might help to identify the sexual 
network and determine groups for targeting with specific public 
health interventions
9,11,16,17,19,23,29,32,34,36,37,42,45-47,55
 
- the associations found between specific sequence types and 
sub-groups of the population might be useful for identifying and 
possibly quantifying the mixing between different groups, such 
as MSM and heterosexuals, which may help estimate the effect 
of tailored public health messages to one group vs the whole 
population
15,16
 
- STI testing recommendations may be tailored based on 
whether the NG strain is associated with coinfection with 
another STI, including HIV
11,17,24,27
 
 
 
NG = Neisseria gonorrhoeae  MSM = men who have sex with men 
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Discussion 
This systematic review identified 49 studies between 2004 and 2017 that used molecular 
typing data linked to patient-level epidemiological data to describe sexual networks of N. 
gonorrhoeae and AMR infection. NG-MAST was the most frequently used typing method, 
but WGS has become increasingly popular in more recent years. These molecular data have 
informed our understanding about the mutability of the N. gonorrhoeae genome, the 
relationship between genotype and phenotype, and the pathogen population structure, which 
provide vital insights into the epidemiology of gonorrhoea and AMR spread. However, linked 
epidemiological data were often limited; with gender and sexual orientation the most 
commonly reported variables. Although details of sexual networks were inferred and the 
public health application of the study findings hypothesised, their value within public health 
interventions has yet to be systematically evaluated. Consequently, it remains unclear 
whether molecular epidemiological studies of N. gonorrhoeae are superior to traditional 
epidemiological studies without molecular data, such as routinely collected surveillance data 
and research studies using patient questionnaires of reported behaviour, when it comes to 
improving infection control or reducing the spread of N. gonorrhoeae and associated AMR.  
 
Our review used systematic methods to identify and assess the relevant literature. The use 
of precise search terms applied to large medical literature databases reduced the risk of 
missing studies. Use of two independent reviewers to select studies and extract data 
minimised the risk of observer bias. A limitation of this review is that only English language 
studies were included. 
 
The included studies highlight that molecular typing data are useful for understanding sexual 
networks, but also that there is often more than one explanation for the findings, which might 
make it difficult to determine appropriate public health actions. For example, a particular 
strain of N. gonorrhoeae identified in both MSM and heterosexuals might be explained by 
bridging between these sexual networks, or de novo independent generation of the 
sequence type. Similarly, where no sexual networks of sub-populations were identified, such 
as within the MSM community, this might be interpreted as being driven by disassortative 
sexual mixing and indicative of high rates of partner change, or it might be that there was 
insufficient epidemiological information collected to distinguish separate sexual networks. 
We found it important to understand the sampling strategy used by molecular 
epidemiological studies to interpret the results and application within public health 
interventions. There is a risk of low internal and external validity if authors use restrictive 
sampling criteria, such as a specific AMR phenotype, or use a convenience sample without 
consideration of the isolates which are excluded. Inappropriate extrapolation is compounded 
if studies compare findings or use data from other studies without consideration of the 
different sampling strategies used. In order to improve the validity and use of molecular 
epidemiological studies, the sampling strategy should aim to reduce the chance of selection 
bias, for example by including consecutive isolates across a representative sample of the 
population. However, we note that the aim and objectives of the studies identified in this 
review varied and were not always intended to identify sexual networks. 
We found conflicting results with respect to associations identified between particular patient 
variables and sequence types, such as whether different strains of N. gonorrhoeae are 
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circulating amongst people living with HIV compared to those not living with HIV. These 
differences are likely due to the different populations and sexual behaviours of people in the 
areas under investigation. Given that populations and their behaviours may differ markedly, 
care should be taken when extrapolating findings from one area to another, and local 
analyses may be required. Consequently, the public health action from these findings may 
also be specific to local areas.  
Many of the studies have hypothesised how molecular data might support the development 
and evaluation of public health interventions. Some studies demonstrated how molecular 
data were used to confirm clustering of infections in an outbreak. However, many of the 
other suggested public health applications, such as tailoring and targeting health promotion 
messages to specific groups or by changing clinical management protocols (for example by 
recalling patients back for test-of-cure depending on the infecting strain of the molecular 
data) are yet to be applied or properly evaluated.    
In conclusion, linking DNA-based sequence typing data to patient-level epidemiological data 
can improve scientific knowledge on the structure of sexual networks and dissemination of 
N. gonorrhoeae and associated AMR. Future molecular epidemiological studies should, 
however, place greater emphasis on determining specific applications of molecular typing 
within public health interventions for controlling gonorrhoea. Greater collaboration between 
those involved in molecular epidemiological research and public health practitioners might 
facilitate evaluation of the public health potential of these increasingly prevalent 
technologies. 
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